PCM
EVH icon

Portolan Capital Management’s Evolent Health EVH Stock Holding History

Portolan Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-720,484
Closed -$9.06M – 90
2019
Q1 		$9.06M Buy
+720,484
New +$11.4M 0.93% 40

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Portolan Capital Management's EVH Position: Q2 2019 in Review

Portolan Capital Management sold out of Evolent Health (EVH) in Q2 2019, closing a stake of 720,484 shares — an estimated $9.06M sold.

Portolan Capital Management first reported a position in EVH in Q1 2019 and held it in 1 quarter. The position peaked at $9.06M in Q1 2019. 183 funds tracked by Wall St. Rank hold EVH as of Q2 2019.

  • Portolan Capital Management reported no remaining Evolent Health position as of Q2 2019 after selling out during the quarter.
  • Portolan Capital Management sold 720,484 Evolent Health shares in Q2 2019, an estimated $9.06M.
  • Portolan Capital Management first reported a position in Evolent Health in Q1 2019 and held it in 1 quarter.
  • Portolan Capital Management's Evolent Health position peaked at $9.06M in Q1 2019.
  • 183 funds tracked by Wall St. Rank held Evolent Health as of Q2 2019.

Based on Portolan Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.